These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27093170)

  • 1. Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach.
    Spanevello F; Calistri A; Del Vecchio C; Mantelli B; Frasson C; Basso G; Palù G; Cavazzana M; Parolin C
    Mol Ther Nucleic Acids; 2016 Apr; 5(4):e312. PubMed ID: 27093170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.
    Anderson J; Akkina R
    AIDS Res Ther; 2005 Jan; 2(1):1. PubMed ID: 15813990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
    Anderson J; Akkina R
    Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV.
    Cordelier P; Morse B; Strayer DS
    Oligonucleotides; 2003; 13(5):281-94. PubMed ID: 15000819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cells.
    Anderson J; Li MJ; Palmer B; Remling L; Li S; Yam P; Yee JK; Rossi J; Zaia J; Akkina R
    Mol Ther; 2007 Jun; 15(6):1182-8. PubMed ID: 17406343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
    Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
    Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.
    Chung J; Zhang J; Li H; Ouellet DL; DiGiusto DL; Rossi JJ
    Hum Gene Ther; 2012 Nov; 23(11):1200-8. PubMed ID: 22834872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
    Morris KV; Rossi JJ
    Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
    Li MJ; Kim J; Li S; Zaia J; Yee JK; Anderson J; Akkina R; Rossi JJ
    Mol Ther; 2005 Nov; 12(5):900-9. PubMed ID: 16115802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance.
    Anderson J; Banerjea A; Akkina R
    Oligonucleotides; 2003; 13(5):303-12. PubMed ID: 15000821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy Analysis of Combinatorial siRNAs against HIV Derived from One Double Hairpin RNA Precursor.
    Liu C; Liang Z; Kong X
    Front Microbiol; 2017; 8():1651. PubMed ID: 28900421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance.
    Tamhane M; Akkina R
    AIDS Res Ther; 2008 Jul; 5():16. PubMed ID: 18667075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral-mediated delivery of combined HIV-1 decoy TAR and Vif siRNA as a single RNA molecule that cleaves to inhibit HIV-1 in transduced cells.
    Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Abumi Y; Ishikawa K; Yamamoto N
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):431-4. PubMed ID: 16247965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial RNAi against HIV-1 using extended short hairpin RNAs.
    Liu YP; von Eije KJ; Schopman NC; Westerink JT; ter Brake O; Haasnoot J; Berkhout B
    Mol Ther; 2009 Oct; 17(10):1712-23. PubMed ID: 19672247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
    Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F
    PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
    D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
    J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
    Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A
    RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.
    ter Brake O; 't Hooft K; Liu YP; Centlivre M; von Eije KJ; Berkhout B
    Mol Ther; 2008 Mar; 16(3):557-64. PubMed ID: 18180777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.
    Anderson J; Akkina R
    Retrovirology; 2005 Aug; 2():53. PubMed ID: 16109172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.